BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 29740313)

  • 1. Epigenome-Wide Association Study of Soluble Tumor Necrosis Factor Receptor 2 Levels in the Framingham Heart Study.
    Mendelson MM; Johannes R; Liu C; Huan T; Yao C; Miao X; Murabito JM; Dupuis J; Levy D; Benjamin EJ; Lin H
    Front Pharmacol; 2018; 9():207. PubMed ID: 29740313
    [No Abstract]   [Full Text] [Related]  

  • 2. Prolonged activation of tumor necrosis factor (TNF)-alpha and its soluble receptors in chronic heart failure patients both in the compensated and decompensated state. Interplay between their levels and metalloproteinase-3.
    Tziakas D; Chalikias G; Parissis JT; Hatzinikolaou H; Stakos D; Papadopoulou E; Kortsaris A; Hatseras D
    Eur Cytokine Netw; 2004; 15(3):231-9. PubMed ID: 15542448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance.
    Fernández-Real JM; Broch M; Ricart W; Casamitjana R; Gutierrez C; Vendrell J; Richart C
    Diabetes; 1998 Nov; 47(11):1757-62. PubMed ID: 9792545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Methylation Signals With Incident Coronary Heart Disease in an Epigenome-Wide Assessment of Circulating Tumor Necrosis Factor α.
    Aslibekyan S; Agha G; Colicino E; Do AN; Lahti J; Ligthart S; Marioni RE; Marzi C; Mendelson MM; Tanaka T; Wielscher M; Absher DM; Ferrucci L; Franco OH; Gieger C; Grallert H; Hernandez D; Huan T; Iurato S; Joehanes R; Just AC; Kunze S; Lin H; Liu C; Meigs JB; van Meurs JBJ; Moore AZ; Peters A; Prokisch H; Räikkönen K; Rathmann W; Roden M; Schramm K; Schwartz JD; Starr JM; Uitterlinden AG; Vokonas P; Waldenberger M; Yao C; Zhi D; Baccarelli AA; Bandinelli S; Deary IJ; Dehghan A; Eriksson J; Herder C; Jarvelin MR; Levy D; Arnett DK
    JAMA Cardiol; 2018 Jun; 3(6):463-472. PubMed ID: 29617535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNF-α and soluble forms of TNF receptors 1 and 2 in the serum of patients with Crohn's disease and ulcerative colitis.
    Owczarek D; Cibor D; Głowacki MK; Cieśla A; Mach P
    Pol Arch Med Wewn; 2012; 122(12):616-23. PubMed ID: 23160117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor system activity is associated with insulin resistance and dyslipidemia in myotonic dystrophy.
    Fernández-Real JM; Molina A; Broch M; Ricart W; Gutiérrez C; Casamitjana R; Vendrell J; Soler J; Gómez-Sáez JM
    Diabetes; 1999 May; 48(5):1108-12. PubMed ID: 10331417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble tumour necrosis factor receptors sTNFR1 and sTNFR2 are produced at sites of inflammation and are markers of arthritis activity in Behçet's disease.
    Turan B; Pfister K; Diener PA; Hell M; Möller B; Boyvat A; Ergin S; Villiger PM
    Scand J Rheumatol; 2008; 37(2):135-41. PubMed ID: 18415772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor alpha (TNF-α) and its soluble receptors are associated with disability, disability progression and clinical forms of multiple sclerosis.
    Ribeiro CM; Oliveira SR; Alfieri DF; Flauzino T; Kaimen-Maciel DR; Simão ANC; Maes M; Reiche EMV
    Inflamm Res; 2019 Dec; 68(12):1049-1059. PubMed ID: 31559449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus.
    Svenungsson E; Gunnarsson I; Fei GZ; Lundberg IE; Klareskog L; Frostegård J
    Arthritis Rheum; 2003 Sep; 48(9):2533-40. PubMed ID: 13130473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of soluble tumor necrosis factor-alpha receptor 2 are linked to insulin resistance and glucose intolerance in children.
    Gupta A; Ten S; Anhalt H
    J Pediatr Endocrinol Metab; 2005 Jan; 18(1):75-82. PubMed ID: 15679072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenome-wide association studies in asthma: A systematic review.
    Edris A; den Dekker HT; Melén E; Lahousse L
    Clin Exp Allergy; 2019 Jul; 49(7):953-968. PubMed ID: 31009112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma levels of the soluble fraction of tumor necrosis factor receptors 1 and 2 are independent determinants of plasma cholesterol and LDL-cholesterol concentrations in healthy subjects.
    Fernández-Real JM; Gutiérrez C; Ricart W; Castiñeira MJ; Vendrell J; Richart C
    Atherosclerosis; 1999 Oct; 146(2):321-7. PubMed ID: 10532687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levels of TNF-α, soluble TNF receptors (sTNFR1, sTNFR2), and cognition in bipolar disorder.
    Doganavsargil-Baysal O; Cinemre B; Aksoy UM; Akbas H; Metin O; Fettahoglu C; Gokmen Z; Davran F
    Hum Psychopharmacol; 2013 Mar; 28(2):160-7. PubMed ID: 23532748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing Type D personality and older age as correlates of tumor necrosis factor-alpha dysregulation in chronic heart failure.
    Denollet J; Vrints CJ; Conraads VM
    Brain Behav Immun; 2008 Jul; 22(5):736-43. PubMed ID: 18068948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type D personality is associated with increased levels of tumour necrosis factor (TNF)-alpha and TNF-alpha receptors in chronic heart failure.
    Conraads VM; Denollet J; De Clerck LS; Stevens WJ; Bridts C; Vrints CJ
    Int J Cardiol; 2006 Oct; 113(1):34-8. PubMed ID: 16325284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory cytokine kinetics to single bouts of acute moderate and intense aerobic exercise in women with active and inactive systemic lupus erythematosus.
    Perandini LA; Sales-de-Oliveira D; Mello S; Camara NO; Benatti FB; Lima FR; Borba E; Bonfa E; Roschel H; Sá-Pinto AL; Gualano B
    Exerc Immunol Rev; 2015; 21():174-85. PubMed ID: 25825870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma soluble tumour necrosis factor-alpha receptor 2 is elevated in obesity: specific contribution of visceral adiposity.
    Cartier A; Côté M; Bergeron J; Alméras N; Tremblay A; Lemieux I; Després JP
    Clin Endocrinol (Oxf); 2010 Mar; 72(3):349-57. PubMed ID: 19650780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infliximab therapy balances regulatory T cells, tumour necrosis factor receptor 2 (TNFR2) expression and soluble TNFR2 in sarcoidosis.
    Verwoerd A; Hijdra D; Vorselaars AD; Crommelin HA; van Moorsel CH; Grutters JC; Claessen AM
    Clin Exp Immunol; 2016 Aug; 185(2):263-70. PubMed ID: 27158798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 2 diabetes and leucocyte DNA methylation: an epigenome-wide association study in over 1,500 older adults.
    Florath I; Butterbach K; Heiss J; Bewerunge-Hudler M; Zhang Y; Schöttker B; Brenner H
    Diabetologia; 2016 Jan; 59(1):130-138. PubMed ID: 26433941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levels of soluble tumor necrosis factor receptor 1 and 2, gender, and risk of myocardial infarction in Northern Sweden.
    Carlsson AC; Jansson JH; Söderberg S; Ruge T; Larsson A; Ärnlöv J
    Atherosclerosis; 2018 May; 272():41-46. PubMed ID: 29547707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.